Research Site — Dayton, Ohio

Research Site is a clinical research site located in Dayton, Ohio, United States 45417.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Research Site has participated in 121 clinical trials with 12 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Asthma, Epithelial Ovarian Cancer.

Sponsors: Biogen, Pearl Therapeutics, Inc., AstraZeneca.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 121 clinical trials on record, with 12 currently active. Their work covers Relapsing Multiple Sclerosis, Asthma, Epithelial Ovarian Cancer.

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.